CDK7-IN-6 is a potent and selective cyclin-dependent kinase ( CDK7 ) inhibitor ( IC 50 ≤100 nM), extracted from patent WO2019197549 A1, compound 210. CDK7-IN-6 is > 200-fold selective for CDK7 over CDK1 , CDK2 , and CDK5. CDK7-IN-6 can be used for the research of cancer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.